The Expert Advisory Group (EAG) advises the Governance Board and the Executive Director on the Medicines Patent Pool licence negotiations and assesses whether the terms and conditions of the proposed licence agreements meet the key requirements as set out by the Medicines Patent Pool Statutes. Individual members of the EAG are also consulted by the Executive Director in their particular area of expertise that is relevant to the work of the MPP.
In selecting the members of the EAG, the Governance Board has sought to bring in expertise in the following areas, while achieving an appropriate geographical and gender balance:
Members of the EAG act solely in their personal capacity.
The Scientific Advisory Panel (SAP), created in 2019, is composed of a pool of subject-matter experts who provide guidance and critical insights to the EAG and the Executive Director.
Access the Scientific Advisory Panel (SAP) members’ list